Company Description
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. They have additional offices in the US, Canada, Australia, Japan and throughout Europe. Biogen Idec has a direct commercial presence in 29 markets, a network of distribution partners in more than 70 additional markets and operations in several new markets, including Central/Eastern Europe, Brazil, China and India.
Contact Info
Corporate Headquartoers
225 Binney Street
Cambridge, MA 02142
Phone: 781-464-2000
Mailing Address
14 Cambridge Center
Cambridge, MA 02142
Offices in the US
Weston, MA
133 Boston Post Road
Weston, MA 02493
Phone: 781-464-2000
North Carolina
U.S. Manufacturing and Patient Services Operations
P.O. Box 14627
5000 Davis Drive
Research Triangle Park, NC 27709-4627
Phone: 919-993-1100
Washington, DC
Government Relations
601 Pennsylvania Ave., N.W.
Suite 720
Washington, DC 20004
Phone: 202-383-1440
See our Cookie Privacy Policy Here
